We are live on ! Find out more
MG

Marex Group Portfolio holdings

AUM $15.8B
1-Year Est. Return 31.44%
This Fund
S&P 500
This Quarter Est. Return
+25.67%
1 Year Est. Return
+31.44%
3 Year Est. Return
+143.62%
5 Year Est. Return
10 Year Est. Return
AUM
$11.5B
AUM Growth
+$6.31B
Cap. Flow
+$5.08B
Cap. Flow %
44.03%
Top 10 Hldgs %
42.58%
Holding
980
New
298
Increased
138
Reduced
168
Closed
338

Top Buys

Rank Stock Value
1
MA icon
Mastercard
MA
+$281M
2
BKNG icon
Booking.com
BKNG
+$169M
3
HUM icon
Humana
HUM
+$76.2M
4
RGTI icon
Rigetti Computing
RGTI
+$74.6M
5
MSTR icon
Strategy Inc
MSTR
+$74.1M

Top Sells

Rank Stock Value
1
IBIT icon
iShares Bitcoin Trust
IBIT
+$359M
2
BRRR icon
Coinshares Bitcoin ETF
BRRR
+$210M
3
NVDA icon
NVIDIA
NVDA
+$157M
4
AVGO icon
Broadcom
AVGO
+$123M
5
NFLX icon
Netflix
NFLX
+$114M

Sector Composition

Rank Sector Weight
1 Technology 15.53%
2 Financials 8.74%
3 Consumer Discretionary 7.67%
4 Healthcare 7.01%
5 Industrials 1.97%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PDSB icon
626
PDS Biotechnology
PDSB
$39.2M
$18.6K ﹤0.01%
14,000
CGC
627
PUT
Canopy Growth
CGC
$382M
$17.6K ﹤0.01%
+14,400
New +$19.2K
IMUX icon
628
Immunic
IMUX
$195M
$15.7K ﹤0.01%
2,250
ORGN
629
DELISTED
Origin Materials
ORGN
$14.5K ﹤0.01%
1,000
+333
+50% +$5.64K
NIVF
630
NewGenIvf
NIVF
$4.17M
$10.4K ﹤0.01%
+11
New +$28.5K
HCAI
631
Huachen AI Parking Management Technology
HCAI
$6.13M
$8.09K ﹤0.01%
+333
New +$60K
CHPT icon
632
ChargePoint
CHPT
$140M
$7.49K ﹤0.01%
533
+25
+5% +$335
MHUA
633
DELISTED
Meihua International Medical Technologies
MHUA
$6.49K ﹤0.01%
162
+42
+35% +$1.55K
ISRLW
634
DELISTED
Israel Acquisitions Corp Warrant
ISRLW
$5.95K ﹤0.01%
+28,333
New +$4.87K
SPKLW
635
Spark I Acquisition Corp Warrant
SPKLW
$8.3M
$3.02K ﹤0.01%
+18,833
New +$3.37K
SCD.RT
636
DELISTED
LMP Capital and Income Fund Inc. Rights (expiring July 11, 2025)
SCD.RT
$711 ﹤0.01%
+10,000
New +$1.13K
ORGNW
637
DELISTED
Origin Materials Inc Warrants
ORGNW
$495 ﹤0.01%
30,000
MNYWW
638
MoneyHero Ltd Warrants
MNYWW
$425 ﹤0.01%
11,320
ARKOW
639
DELISTED
ARKO Corp Warrant
ARKOW
$408 ﹤0.01%
+40,000
New +$836
KTTAW icon
640
Pasithea Therapeutics Warrants
KTTAW
$26K
$388 ﹤0.01%
25,000
GOVXW
641
DELISTED
GeoVax Labs Warrants
GOVXW
$250 ﹤0.01%
10,000
AA icon
642
Alcoa
AA
$11.9B
-19,074
Closed -$582K
ABG icon
643
Asbury Automotive
ABG
$4.14B
-31,665
Closed -$6.99M
ACN icon
644
Accenture
ACN
$84.9B
-1,346
Closed -$420K
ACRV icon
645
Acrivon Therapeutics
ACRV
$71.5M
-14,080
Closed -$28.6K
ACWI icon
646
iShares MSCI ACWI ETF
ACWI
$32.7B
-25,120
Closed -$2.92M
ADSK icon
647
Autodesk
ADSK
$43.3B
-925
Closed -$242K
AEF
648
abrdn Emerging Markets Equity Income Fund
AEF
$359M
-114,903
Closed -$570K
AEYE icon
649
AudioEye
AEYE
$72.2M
-63,984
Closed -$710K
ALC icon
650
Alcon
ALC
$32.8B
-3,145
Closed -$299K

Similar funds

Marex Group's Q2 2025 Portfolio in Review

As of Q2 2025, Marex Group held 980 positions worth $11.5B, up 121% from $5.22B the previous quarter. Its ten largest holdings account for 43% of the portfolio.

Marex Group deployed $5.08B of net new capital in Q2 2025, opening 298 new positions and adding to 138 existing holdings. Its largest new stake was Humana: 305,720 shares worth $74.7M.

By sector, the portfolio is most concentrated in Technology at 16% of assets, down from 31% a quarter earlier, followed by Financials and Consumer Discretionary.

On the sell side, the largest reduction was iShares Bitcoin Trust, an estimated $359M trimmed.

  • Marex Group's largest Q2 2025 buy was Humana: 305,720 shares worth $74.7M.
  • Marex Group added most to Mastercard in Q2 2025, an estimated $281M increase.
  • Marex Group's biggest Q2 2025 reduction was iShares Bitcoin Trust, cutting an estimated $359M.
  • Marex Group fully exited Coinshares Bitcoin ETF in Q2 2025, selling an estimated $210M.
  • Marex Group's ten largest holdings make up 43% of its $11.5B portfolio in Q2 2025.
  • Marex Group opened 298 new positions and closed 338 in Q2 2025.
  • Marex Group's portfolio value rose 121% quarter-over-quarter to $11.5B.

Based on Marex Group's 13F filing for Q2 2025, filed 19 Aug 2025.